- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents ; volume:5 ; number:1 ; day:28 ; month:9 ; year:2024 ; pages:1-19 ; date:12.2024
Molecular biomedicine ; 5, Heft 1 (28.9.2024), 1-19, 12.2024
- Urheber
-
Dhas, Yogita
Biswas, Nupur
M.R., Divyalakshmi
Jones, Lawrence D.
Ashili, Shashaanka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-024-00204-z
- URN
-
urn:nbn:de:101:1-2412012108320.282069521106
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.03.2025, 09:05 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dhas, Yogita
- Biswas, Nupur
- M.R., Divyalakshmi
- Jones, Lawrence D.
- Ashili, Shashaanka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
Heterocyclic anticancer agents
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
The effects of antidiabetic agents on heart failure
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
Thiadiazole derivatives as anticancer agents
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Similarity searching for anticandidal agents employing a repurposing approach
Repurposing metformin as a potential anticancer agent using in silico technique
In the Search of Glycoside-Based Molecules as Antidiabetic Agents
Structure‐Agnostic Bioactivity‐Driven Combinatorial Biosynthesis Reveals New Antidiabetic and Anticancer Triterpenoids
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
Heterocyclic anticancer agents
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
The effects of antidiabetic agents on heart failure
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
Thiadiazole derivatives as anticancer agents
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Similarity searching for anticandidal agents employing a repurposing approach
Repurposing metformin as a potential anticancer agent using in silico technique
In the Search of Glycoside-Based Molecules as Antidiabetic Agents
Structure‐Agnostic Bioactivity‐Driven Combinatorial Biosynthesis Reveals New Antidiabetic and Anticancer Triterpenoids
Drug repurposing against COVID-19: focus on anticancer agents
Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
Heterocyclic anticancer agents
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents
The effects of antidiabetic agents on heart failure
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
Thiadiazole derivatives as anticancer agents
Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study
Similarity searching for anticandidal agents employing a repurposing approach
Repurposing metformin as a potential anticancer agent using in silico technique
In the Search of Glycoside-Based Molecules as Antidiabetic Agents